Elena Biagini
Bologna, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 176 publications
International Experience With Implantable Cardioverter Defibrillators for the Prevention of Sudden Death in High-Risk Patients With Hypertrophic Cardiomyopathy.
Journal: Circulation
Published: August 25, 2026
Variant Site-Specific Natural History of Titin-Induced Cardiomyopathy: An International Multicenter Registry.
Journal: Circulation. Genomic and precision medicine
Published: July 08, 2026
Predictors of Long-Term Outcomes in Hypertrophic Cardiomyopathy: The NHLBI HCM Registry.
Journal: JAMA
Published: May 11, 2026
The ODYSSEY-HCM and MAPLE-HCM studies: the role of cardiac myosin inhibitors in hypertrophic cardiomyopathy (obstructive and non-obstructive).
Journal: European heart journal supplements : journal of the European Society of Cardiology
Published: May 08, 2026
Non-dilated left ventricular cardiomyopathy: beyond morphology, towards diagnostic precision
Journal: Giornale italiano di cardiologia (2006)
Published: February 25, 2026
Prevalence and Prognostic Significance of Restriction Versus Systolic Dysfunction in Patients With Transthyretin and Light Chain Cardiac Amyloidosis.
Journal: Circulation. Heart failure
Published: February 24, 2026
Cardiovascular Morbidity and Mortality in Fabry Disease.
Journal: Circulation. Genomic and precision medicine
Published: February 06, 2026
Immunogenicity in Fabry Disease: Current Issues, Coping Strategies, and Future Directions.
Journal: Biomedicines
Published: December 22, 2025
Cardiological aspects of Fabry disease: from diagnosis to therapeutic efficacy assessment.
Journal: Orphanet journal of rare diseases
Published: December 05, 2025
Last Updated: 09/26/2026